January 09, 2025

Medicare Covers Tirzepatide for Sleep Apnea

Eli Lilly's tirzepatide gets Medicare coverage for sleep apnea, widening access to weight-loss treatment. Are obesity drugs getting a breakthrough?

Reuters

January 08, 2025

J&J Pauses U.S. Heart Device Rollout

Johnson & Johnson pauses Varipulse heart device rollout in the U.S. after reported stroke events, affecting their stock value.

Reuters

January 07, 2025

RSV Vaccines Add Guillain-Barré Warning

FDA flags increased GBS risk with GSK and Pfizer's respiratory syncytial virus vaccines, Arexvy and Abrysvo.

Reuters

January 03, 2025

Surgeon General Issues Advisory on Alcohol, Cancer Link

Of all breast cancer cases in the U.S., 16.4% are directly linked to alcohol consumption.

Conexiant

January 02, 2025

Trio of Trials Track Early Migraine Drug Response

Day 1 efficacy data from 3 trials reveal atogepant's rapid impact in reducing migraine frequency, with functional improvements as early as week 1.

Conexiant

December 30, 2024

Axsome Pursues Approval for Agitation Drug

Axsome Therapeutics seeks marketing approval for its oral drug targeting agitation in Alzheimer's patients, showing promising results in late-stage studies.

Reuters

December 27, 2024

11 Medical Breakthroughs This Year

Explore medical breakthroughs from 2024, including advancements in Parkinson’s therapy, ulcerative colitis treatments, and gene therapy for hereditary deafness.

Conexiant

December 23, 2024

Trump Team Targets Immediate WHO Exit, Experts Say

"I have it on good authority that he plans to withdraw, probably on Day One or very early in his administration."

Reuters

December 19, 2024

Vertex Pain Drug Falls Short vs. Placebo

Vertex Pharmaceuticals' non-opioid drug, suzetrigine, showed little difference versus a placebo in reducing pain for lumbosacral radiculopathy, prompting FDA review for treating moderate-to-severe acute pain.

Reuters